AINewsnow

Biomatter raises $18M Series A to scale AI enzyme design platform

Vilnius-based Biomatter closed an oversubscribed $18 million Series A led by Astanor, with participation from existing investors UVC Partners, Inventure and Metaplanet, to expand its AI enzyme design and testing.

Read the full story at Tech.eu ↗

Timeline · 3 reports

  1. 2026-11-12 12:03 · Unite.AI
    Biomatter Raises $18M Series A to Expand AI Enzyme Design and Testing
  2. 2026-11-12 09:45 · The Next Web
    Lithuania’s Biomatter raises $18M for AI enzyme design
  3. 2026-11-12 08:51 · Tech.eu
    Biomatter lands $18M to speed up enzyme development with AI

More stories

  1. The phantom life of Alice Huang, alleged Chinese spy who had affair with Nvidia CEO — CSET Georgetown
  2. Google DeepMind unveils AlphaGenome 2 for cell-type-specific DNA variant predictions — Google DeepMind Blog
  3. Google DeepMind's AlphaProof Code formally verifies Signal's cryptographic code in four weeks — Google DeepMind Blog
  4. Google launches Gemini Decision 1 model and Decisions API for fast closed-set choices — Google Cloud AI Blog
  5. Google launches Tabletop, an experimental AI platform for group planning and collaboration — Google AI Blog
  6. United Airlines to Ban AI Bots From Booking Flights — Wall Street Journal Technology
  7. Google expands Gemini 4 Carbon access to Pro plan users in AI Mode — Google DeepMind Blog
  8. AI chip startup Fractile raises $720M at $7B valuation — Techmeme

Get the daily brief of stories like this at 6:30 every morning →